25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

INAB (In8bio) Stock Analysis
Buy, Hold or Sell?

Let's analyze In8bio together

I guess you are interested in In8bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – In8bio’s Financial Insights
  • 📈 Technical Analysis (TA) – In8bio’s Price Targets

I'm going to help you getting a better view of In8bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about In8bio Inc

I send you an email if I find something interesting about In8bio Inc.

1. Quick Overview

1.1. Quick analysis of In8bio (30 sec.)










1.2. What can you expect buying and holding a share of In8bio? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-0.29
How sure are you?
29.2%

+ What do you gain per year?

Total Gains per Share
$-0.30
Return On Investment
-14.9%

For what price can you sell your share?

Current Price per Share
$2.00
Expected price per share
$1.91 - $2.534
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of In8bio (5 min.)




Live pricePrice per Share (EOD)
$2.00
Intrinsic Value Per Share
$10.28 - $12.70
Total Value Per Share
$10.29 - $12.70

2.2. Growth of In8bio (5 min.)




Is In8bio growing?

Current yearPrevious yearGrowGrow %
How rich?$15.2m$18.4m-$5.4m-41.5%

How much money is In8bio making?

Current yearPrevious yearGrowGrow %
Making money-$5.9m-$7.9m$2m33.8%
Net Profit Margin-61.0%-50.7%--

How much money comes from the company's main activities?

2.3. Financial Health of In8bio (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#510 / 853

Most Revenue
#492 / 853

Most Profit
#438 / 853

Most Efficient
#412 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of In8bio?

Welcome investor! In8bio's management wants to use your money to grow the business. In return you get a share of In8bio.

First you should know what it really means to hold a share of In8bio. And how you can make/lose money.

Speculation

The Price per Share of In8bio is $2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of In8bio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in In8bio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of In8bio.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.1%-0.08-3.8%-0.21-10.4%-0.20-9.8%-0.21-10.4%-0.19-9.7%
Usd Book Value Change Per Share-0.16-8.1%-0.07-3.7%-0.12-5.8%-0.12-5.9%0.00-0.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.16-8.1%-0.07-3.7%-0.12-5.8%-0.12-5.9%0.00-0.1%0.000.0%
Usd Price Per Share2.09-0.70-1.11-1.20-1.56-1.30-
Price to Earnings Ratio-422.51--106.08--1.34--36.29--22.63--18.86-
Price-to-Total Gains Ratio-12.86--1.50--1.77--4.13--5.02--5.02-
Price to Book Ratio564.93-142.18-2.39-48.85-29.74-24.78-
Price-to-Total Gains Ratio-12.86--1.50--1.77--4.13--5.02--5.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2
Number of shares500
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.00
Usd Total Gains Per Share-0.070.00
Gains per Quarter (500 shares)-37.27-1.32
Gains per Year (500 shares)-149.07-5.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-149-1590-5-15
20-298-3080-11-20
30-447-4570-16-25
40-596-6060-21-30
50-745-7550-26-35
60-894-9040-32-40
70-1044-10530-37-45
80-1193-12020-42-50
90-1342-13510-48-55
100-1491-15000-53-60

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.024.00.00.0%0.024.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%7.017.00.029.2%7.017.00.029.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.024.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%7.017.00.029.2%7.017.00.029.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of In8bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.163-0.075-54%-0.116-29%-0.117-28%-0.003-98%0.000-105536%
Book Value Per Share--0.0040.138-97%0.492-99%0.521-99%0.815-100%0.681-99%
Current Ratio--7.0324.315+63%3.715+89%4.249+66%6.863+2%5.892+19%
Debt To Asset Ratio--0.2130.321-34%0.323-34%0.309-31%0.272-22%0.392-46%
Debt To Equity Ratio--0.2710.502-46%0.484-44%0.461-41%0.503-46%0.742-63%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--8618123770.0002167639943.788+298%48690677.757+17600%756710407.047+1039%594742991.249+1349%594742991.249+1349%
Eps---0.001-0.076+6014%-0.207+16649%-0.197+15817%-0.208+16753%-0.194+15584%
Ev To Ebitda Ratio---422.955-106.338-75%-1.631-100%-36.614-91%-28.932-93%-28.932-93%
Free Cash Flow Per Share---0.001-0.055+5715%-0.161+16746%-0.174+18189%-0.180+18814%-0.159+16629%
Free Cash Flow To Equity Per Share--0.000-0.005+1770%-0.037+11522%-0.046+14154%0.032-99%0.034-99%
Gross Profit Margin--1.0001.0000%1.039-4%1.013-1%1.008-1%1.006-1%
Intrinsic Value_10Y_max--12.697----------
Intrinsic Value_10Y_min--10.283----------
Intrinsic Value_1Y_max---0.413----------
Intrinsic Value_1Y_min---0.407----------
Intrinsic Value_3Y_max--0.044----------
Intrinsic Value_3Y_min--0.016----------
Intrinsic Value_5Y_max--2.049----------
Intrinsic Value_5Y_min--1.791----------
Market Cap9079440.000-94719%8609029770.0002163573193.788+298%42878677.757+19978%750188573.714+1048%465916992.999+1748%388264160.832+2117%
Net Profit Margin----0.6100%-0.5070%-2.2720%-1.3630%-1.1360%
Operating Margin----0.6100%-0.5290%-2.2800%-1.3680%-1.1400%
Operating Ratio---0.741-100%0.571-100%2.486-100%1.492-100%1.243-100%
Pb Ratio540.607-4%564.934142.177+297%2.387+23564%48.846+1057%29.740+1800%24.784+2179%
Pe Ratio-404.314+4%-422.508-106.085-75%-1.342-100%-36.293-91%-22.627-95%-18.856-96%
Price Per Share2.000-4%2.0900.696+200%1.112+88%1.200+74%1.562+34%1.301+61%
Price To Free Cash Flow Ratio-524.466+4%-548.067-137.713-75%-1.768-100%-46.999-91%-29.141-95%-24.284-96%
Price To Total Gains Ratio-12.306+4%-12.859-1.495-88%-1.767-86%-4.128-68%-5.018-61%-5.018-61%
Quick Ratio--6.7693.874+75%3.055+122%3.656+85%5.977+13%5.130+32%
Return On Assets---0.263-0.320+22%-0.304+16%-0.291+11%-0.248-6%-0.416+58%
Return On Equity---0.334-0.496+48%-0.458+37%-0.434+30%-0.420+26%-0.773+131%
Total Gains Per Share---0.163-0.075-54%-0.116-29%-0.117-28%-0.003-98%0.000-105536%
Usd Book Value--15239000.00013045500.000+17%18460500.000-17%18075583.333-16%20333350.000-25%16970541.667-10%
Usd Book Value Change Per Share---0.163-0.075-54%-0.116-29%-0.117-28%-0.003-98%0.000-105536%
Usd Book Value Per Share--0.0040.138-97%0.492-99%0.521-99%0.815-100%0.681-99%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--8618123770.0002167639943.788+298%48690677.757+17600%756710407.047+1039%594742991.249+1349%594742991.249+1349%
Usd Eps---0.001-0.076+6014%-0.207+16649%-0.197+15817%-0.208+16753%-0.194+15584%
Usd Free Cash Flow---3927000.000-4284500.000+9%-6219000.000+58%-5996583.333+53%-5030057.650+28%-4327875.417+10%
Usd Free Cash Flow Per Share---0.001-0.055+5715%-0.161+16746%-0.174+18189%-0.180+18814%-0.159+16629%
Usd Free Cash Flow To Equity Per Share--0.000-0.005+1770%-0.037+11522%-0.046+14154%0.032-99%0.034-99%
Usd Market Cap9079440.000-94719%8609029770.0002163573193.788+298%42878677.757+19978%750188573.714+1048%465916992.999+1748%388264160.832+2117%
Usd Price Per Share2.000-4%2.0900.696+200%1.112+88%1.200+74%1.562+34%1.301+61%
Usd Profit---5094000.000-5972500.000+17%-7989500.000+57%-7190416.667+41%-5912700.000+16%-5246583.333+3%
Usd Revenue---631500.000-100%937000.000-100%550333.333-100%330200.000-100%275166.667-100%
Usd Total Gains Per Share---0.163-0.075-54%-0.116-29%-0.117-28%-0.003-98%0.000-105536%
 EOD+3 -5MRQTTM+23 -11YOY+22 -133Y+22 -135Y+19 -1610Y+20 -15

3.3 Fundamental Score

Let's check the fundamental score of In8bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-404.314
Price to Book Ratio (EOD)Between0-1540.607
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.769
Current Ratio (MRQ)Greater than17.032
Debt to Asset Ratio (MRQ)Less than10.213
Debt to Equity Ratio (MRQ)Less than10.271
Return on Equity (MRQ)Greater than0.15-0.334
Return on Assets (MRQ)Greater than0.05-0.263
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of In8bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.354
Ma 20Greater thanMa 502.148
Ma 50Greater thanMa 1002.219
Ma 100Greater thanMa 2002.911
OpenGreater thanClose2.040
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About In8bio Inc

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.

Fundamental data was last updated by Penke on 2025-09-04 02:01:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit In8bio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of In8bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-61.0%+61.0%
TTM-61.0%YOY-50.7%-10.3%
TTM-61.0%5Y-136.3%+75.4%
5Y-136.3%10Y-113.6%-22.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--85.5%+85.5%
TTM-61.0%-171.0%+110.0%
YOY-50.7%-210.0%+159.3%
3Y-227.2%-289.9%+62.7%
5Y-136.3%-381.1%+244.8%
10Y-113.6%-520.3%+406.7%
4.3.1.2. Return on Assets

Shows how efficient In8bio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • -26.3% Return on Assets means that In8bio generated $-0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of In8bio Inc:

  • The MRQ is -26.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -32.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.3%TTM-32.0%+5.7%
TTM-32.0%YOY-30.4%-1.6%
TTM-32.0%5Y-24.8%-7.2%
5Y-24.8%10Y-41.6%+16.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.3%-11.9%-14.4%
TTM-32.0%-11.9%-20.1%
YOY-30.4%-11.2%-19.2%
3Y-29.1%-12.0%-17.1%
5Y-24.8%-11.7%-13.1%
10Y-41.6%-13.8%-27.8%
4.3.1.3. Return on Equity

Shows how efficient In8bio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • -33.4% Return on Equity means In8bio generated $-0.33 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of In8bio Inc:

  • The MRQ is -33.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -49.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.4%TTM-49.6%+16.2%
TTM-49.6%YOY-45.8%-3.9%
TTM-49.6%5Y-42.0%-7.6%
5Y-42.0%10Y-77.3%+35.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.4%-14.2%-19.2%
TTM-49.6%-15.2%-34.4%
YOY-45.8%-15.3%-30.5%
3Y-43.4%-16.9%-26.5%
5Y-42.0%-17.5%-24.5%
10Y-77.3%-19.6%-57.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of In8bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient In8bio is operating .

  • Measures how much profit In8bio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of In8bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-61.0%+61.0%
TTM-61.0%YOY-52.9%-8.1%
TTM-61.0%5Y-136.8%+75.8%
5Y-136.8%10Y-114.0%-22.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM-61.0%-280.2%+219.2%
YOY-52.9%-268.7%+215.8%
3Y-228.0%-281.5%+53.5%
5Y-136.8%-350.8%+214.0%
10Y-114.0%-530.7%+416.7%
4.3.2.2. Operating Ratio

Measures how efficient In8bio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of In8bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.741-0.741
TTM0.741YOY0.571+0.170
TTM0.7415Y1.492-0.751
5Y1.49210Y1.243+0.249
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.952-1.952
TTM0.7412.974-2.233
YOY0.5713.047-2.476
3Y2.4863.835-1.349
5Y1.4924.924-3.432
10Y1.2436.864-5.621
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of In8bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if In8bio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.03 means the company has $7.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of In8bio Inc:

  • The MRQ is 7.032. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.315. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.032TTM4.315+2.717
TTM4.315YOY3.715+0.600
TTM4.3155Y6.863-2.548
5Y6.86310Y5.892+0.971
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0323.480+3.552
TTM4.3153.790+0.525
YOY3.7154.104-0.389
3Y4.2494.609-0.360
5Y6.8635.764+1.099
10Y5.8926.154-0.262
4.4.3.2. Quick Ratio

Measures if In8bio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Quick Ratio of 6.77 means the company can pay off $6.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of In8bio Inc:

  • The MRQ is 6.769. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.874. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.769TTM3.874+2.895
TTM3.874YOY3.055+0.819
TTM3.8745Y5.977-2.103
5Y5.97710Y5.130+0.847
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7692.938+3.831
TTM3.8743.291+0.583
YOY3.0553.928-0.873
3Y3.6564.393-0.737
5Y5.9775.837+0.140
10Y5.1306.549-1.419
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of In8bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of In8bio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare In8bio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.21 means that In8bio assets are financed with 21.3% credit (debt) and the remaining percentage (100% - 21.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of In8bio Inc:

  • The MRQ is 0.213. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.321. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.213TTM0.321-0.108
TTM0.321YOY0.323-0.001
TTM0.3215Y0.272+0.049
5Y0.27210Y0.392-0.119
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2130.339-0.126
TTM0.3210.359-0.038
YOY0.3230.334-0.011
3Y0.3090.341-0.032
5Y0.2720.349-0.077
10Y0.3920.379+0.013
4.5.4.2. Debt to Equity Ratio

Measures if In8bio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.1% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of In8bio Inc:

  • The MRQ is 0.271. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.502. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.502-0.231
TTM0.502YOY0.484+0.018
TTM0.5025Y0.503-0.001
5Y0.50310Y0.742-0.240
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2710.391-0.120
TTM0.5020.436+0.066
YOY0.4840.436+0.048
3Y0.4610.4610.000
5Y0.5030.461+0.042
10Y0.7420.514+0.228
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings In8bio generates.

  • Above 15 is considered overpriced but always compare In8bio to the Biotechnology industry mean.
  • A PE ratio of -422.51 means the investor is paying $-422.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of In8bio Inc:

  • The EOD is -404.314. Based on the earnings, the company is expensive. -2
  • The MRQ is -422.508. Based on the earnings, the company is expensive. -2
  • The TTM is -106.085. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-404.314MRQ-422.508+18.194
MRQ-422.508TTM-106.085-316.423
TTM-106.085YOY-1.342-104.743
TTM-106.0855Y-22.627-83.458
5Y-22.62710Y-18.856-3.771
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-404.314-2.539-401.775
MRQ-422.508-2.361-420.147
TTM-106.085-2.657-103.428
YOY-1.342-3.749+2.407
3Y-36.293-3.883-32.410
5Y-22.627-6.353-16.274
10Y-18.856-7.102-11.754
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of In8bio Inc:

  • The EOD is -524.466. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -548.067. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -137.713. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-524.466MRQ-548.067+23.601
MRQ-548.067TTM-137.713-410.353
TTM-137.713YOY-1.768-135.945
TTM-137.7135Y-29.141-108.573
5Y-29.14110Y-24.284-4.857
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-524.466-3.411-521.055
MRQ-548.067-2.951-545.116
TTM-137.713-3.614-134.099
YOY-1.768-4.421+2.653
3Y-46.999-5.258-41.741
5Y-29.141-8.587-20.554
10Y-24.284-9.639-14.645
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of In8bio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 564.93 means the investor is paying $564.93 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of In8bio Inc:

  • The EOD is 540.607. Based on the equity, the company is expensive. -2
  • The MRQ is 564.934. Based on the equity, the company is expensive. -2
  • The TTM is 142.177. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD540.607MRQ564.934-24.327
MRQ564.934TTM142.177+422.757
TTM142.177YOY2.387+139.789
TTM142.1775Y29.740+112.436
5Y29.74010Y24.784+4.957
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD540.6072.206+538.401
MRQ564.9342.027+562.907
TTM142.1772.194+139.983
YOY2.3872.425-0.038
3Y48.8462.571+46.275
5Y29.7403.805+25.935
10Y24.7844.462+20.322
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of In8bio Inc.

4.8.1. Institutions holding In8bio Inc

Institutions are holding 19.285% of the shares of In8bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BIOS CAPITAL MANAGEMENT, LP7.02931.803860000100
2025-03-31Geode Capital Management, LLC0.464805686315343810.3724
2025-06-30Franklin Resources Inc4.65640.0001189894400.0211
2025-06-30AIGH Capital Management, LLC3.67560.1409149895101566210.1554
2025-03-31Northern Trust Corp0.076409342000
2025-03-31State Street Corp0.072508874600
2025-06-30Alyeska Investment Group, L.P.2.02260.0006824841317219.0039
2025-06-30Stonepine Capital Management Llc2.02130.16982430824300
2025-03-31Chicago Partners Investment Group LLC0.05660.000469301693010
2025-06-30Vanguard Group Inc1.473606009740.0067
2025-03-31BlackRock Inc0.0478058504-1068-1.7928
2025-03-31TWO SIGMA SECURITIES, LLC0.0280.000934279342790
2025-03-31Citadel Advisors Llc0.0241029450294500
2025-03-31Susquehanna International Group, LLP0.0203024812248120
2025-03-31Capital Investment Advisory Services, LLC0.01440.000317605176050
2025-03-31Virtu Financial LLC0.01240.000215110-6880-31.2869
2025-03-31UBS Group AG0.0101012327-46526-79.0546
2025-03-31LPL Financial Corp0.009301135000
2025-03-31HighTower Advisors, LLC0.008201000000
2025-03-31Northwestern Mutual Wealth Management Co0.00680826382630
Total 21.73052.115410206599+379886+3.7%

4.9.2. Funds holding In8bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Franklin Biotechnology Discv A(acc)USD2.94740.018812020000
2025-07-31Franklin Biotechnology Discovery A1.70850.02046967300
2025-07-31Vanguard Total Stock Mkt Idx Inv0.7619031070-679-2.1387
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.47750.000119475-8873-31.3003
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01240.000215110151100
2025-06-30Fidelity Extended Market Index0.25990.00011059810.0094
2025-06-30Fidelity Series Total Market Index0.06360259500
2025-06-30Spartan Extended Market Index Pool F0.05750.0001234300
2025-06-30Northern Trust Extended Eq Market Idx0.05180.00012113-1-0.0473
2025-06-30NT Ext Equity Mkt Idx Fd - L0.05180.00012113-1-0.0473
2025-06-30Fidelity Total Market Index0.0502040-1-0.049
2025-06-30NT Ext Equity Mkt Idx Fd - NL0.02320947-1-0.1055
2025-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0180735-2-0.2714
2025-06-30Spartan Total Market Index Pool G0.0165067200
2025-06-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01460.00015968917.5542
2025-06-30Fidelity Nasdaq Composite Index0.01390567-1-0.1761
2025-07-31State St US Extended Mkt Indx NL Cl C0.01070.000143600
2025-06-30Northern Trust Wilshire 50000.001305200
2025-06-30Fidelity U.S. Equity Index Ins Trust0.00010500
Total 6.54060.0401281340+5641+2.0%

5.3. Insider Transactions

Insiders are holding 5.556% of the shares of In8bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-13Jeremy R GraffBUY8328.5
2023-08-25Patrick MccallBUY3330.9
2023-08-24William Tai-wei HoBUY79331.5
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets19,371
Total Liabilities4,132
Total Stockholder Equity15,239
 As reported
Total Liabilities 4,132
Total Stockholder Equity+ 15,239
Total Assets = 19,371

Assets

Total Assets19,371
Total Current Assets13,741
Long-term Assets5,630
Total Current Assets
Cash And Cash Equivalents 13,226
Other Current Assets 515
Total Current Assets  (as reported)13,741
Total Current Assets  (calculated)13,741
+/-0
Long-term Assets
Property Plant Equipment 5,084
Long-term Assets Other 275
Long-term Assets  (as reported)5,630
Long-term Assets  (calculated)5,359
+/- 271

Liabilities & Shareholders' Equity

Total Current Liabilities1,954
Long-term Liabilities2,178
Total Stockholder Equity15,239
Total Current Liabilities
Short-term Debt 940
Accounts payable 379
Other Current Liabilities 635
Total Current Liabilities  (as reported)1,954
Total Current Liabilities  (calculated)1,954
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,178
Long-term Liabilities  (as reported)2,178
Long-term Liabilities  (calculated)2,178
+/-0
Total Stockholder Equity
Common Stock10
Retained Earnings -132,300
Other Stockholders Equity 147,529
Total Stockholder Equity (as reported)15,239
Total Stockholder Equity (calculated)15,239
+/-0
Other
Capital Stock10
Cash and Short Term Investments 13,226
Common Stock Shares Outstanding 4,119,153
Liabilities and Stockholders Equity 19,371
Net Debt -10,108
Net Invested Capital 15,239
Net Working Capital 11,787
Property Plant and Equipment Gross 7,858
Short Long Term Debt Total 3,118



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302018-03-312017-12-31
> Total Assets 
0
0
0
0
0
0
1,130
1,130
0
3,647
0
20,910
20,423
17,564
47,134
42,223
36,538
30,988
38,383
33,039
24,678
29,718
26,208
33,709
25,549
22,496
15,966
20,944
19,869
19,371
19,37119,86920,94415,96622,49625,54933,70926,20829,71824,67833,03938,38330,98836,53842,22347,13417,56420,42320,91003,64701,1301,130000000
   > Total Current Assets 
0
0
0
0
0
0
763
763
610
3,325
18,144
18,144
15,372
12,167
43,877
38,980
33,274
26,999
29,654
22,234
14,402
19,465
16,549
24,625
15,755
12,682
6,703
12,578
12,725
13,741
13,74112,72512,5786,70312,68215,75524,62516,54919,46514,40222,23429,65426,99933,27438,98043,87712,16715,37218,14418,1443,325610763763000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
610
610
-610
3,180
0
17,994
15,052
11,999
40,675
37,021
32,107
25,742
27,647
18,182
10,860
16,993
12,854
21,282
13,015
10,217
4,001
11,120
11,888
13,226
13,22611,88811,1204,00110,21713,01521,28212,85416,99310,86018,18227,64725,74232,10737,02140,67511,99915,05217,99403,180-610610610000000
       Short-term Investments 
0
0
0
0
0
0
0
0
1,220
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,22000000000
       Other Current Assets 
0
0
0
0
0
0
153
153
0
145
0
150
320
168
3,202
1,959
2,334
2,514
4,004
4,052
3,542
2,472
3,695
3,343
2,740
2,465
2,702
1,458
837
515
5158371,4582,7022,4652,7403,3433,6952,4723,5424,0524,0042,5142,3341,9593,20216832015001450153153000000
   > Long-term Assets 
0
0
0
0
0
0
367
367
-610
322
0
2,766
5,051
5,397
3,257
3,243
3,264
3,989
8,729
10,805
10,276
10,253
9,659
9,084
9,794
9,814
9,263
8,366
7,144
5,630
5,6307,1448,3669,2639,8149,7949,0849,65910,25310,27610,8058,7293,9893,2643,2433,2575,3975,0512,7660322-610367367000000
       Property Plant Equipment 
0
0
0
0
0
0
274
274
0
230
186
186
1,776
1,894
2,848
2,834
2,855
3,491
8,120
10,172
9,768
9,745
9,150
8,573
9,218
9,235
8,499
7,825
6,600
5,084
5,0846,6007,8258,4999,2359,2188,5739,1509,7459,76810,1728,1203,4912,8552,8342,8481,8941,7761861862300274274000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,362
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003,3620000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
126
126
0
0
0
0
0
0
0
0
0
0
0000000000126126000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
2,580
2,580
3,275
3,503
409
409
409
498
483
0
0
508
0
0
0
0
0
-1,043
0
0
00-1,04300000508004834984094094093,5033,2752,5802,5800000000000
> Total Liabilities 
0
0
0
0
0
0
647
1,476
0
2,812
0
2,589
4,104
3,903
4,096
4,040
3,703
4,420
8,819
10,307
7,890
7,919
8,450
8,772
8,023
8,875
7,378
6,466
5,992
4,132
4,1325,9926,4667,3788,8758,0238,7728,4507,9197,89010,3078,8194,4203,7034,0404,0963,9034,1042,58902,81201,476647000000
   > Total Current Liabilities 
0
0
0
0
0
0
647
647
0
1,867
2,572
2,572
3,062
2,773
2,160
2,256
2,068
2,972
4,900
5,822
3,748
3,781
4,686
5,393
3,844
4,759
3,635
3,083
2,957
1,954
1,9542,9573,0833,6354,7593,8445,3934,6863,7813,7485,8224,9002,9722,0682,2562,1602,7733,0622,5722,5721,8670647647000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
58
0
174
770
826
1,256
626
1,262
1,120
1,830
2,778
1,386
3,044
2,996
3,028
3,072
1,782
1,729
1,647
1,237
940
9401,2371,6471,7291,7823,0723,0282,9963,0441,3862,7781,8301,1201,2626261,256826770174058000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
58
0
174
174
174
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000174174174058000000000
       Accounts payable 
0
0
0
0
0
0
560
560
0
561
620
620
660
462
692
395
553
887
1,108
2,091
870
585
748
924
1,413
1,444
1,137
389
575
379
3795753891,1371,4441,4139247485858702,0911,1088875533956924626606206205610560560000000
       Other Current Liabilities 
0
0
0
0
0
0
87
87
0
1,248
876
1,778
1,632
1,485
212
1,235
253
965
1,962
953
1,492
152
942
1,441
-641
1,533
769
1,047
1,145
635
6351,1451,0477691,533-6411,4419421521,4929531,9629652531,2352121,4851,6321,7788761,24808787000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
829
0
945
0
17
1,042
1,130
1,936
1,784
1,635
1,448
3,919
4,485
4,142
4,138
3,764
3,379
4,179
4,116
3,743
3,383
3,035
2,178
2,1783,0353,3833,7434,1164,1793,3793,7644,1384,1424,4853,9191,4481,6351,7841,9361,1301,04217094508290000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
34,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000034,9000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
17
17
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000017170000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
2,439
2,439
3,134
3,362
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003,3623,1342,4392,4390000000000
> Total Stockholder Equity
0
0
0
0
0
0
483
-346
483
835
0
18,321
16,319
13,661
43,038
38,183
32,835
26,568
29,564
22,732
16,788
21,799
17,758
24,937
17,526
13,621
8,588
14,478
13,877
15,239
15,23913,87714,4788,58813,62117,52624,93717,75821,79916,78822,73229,56426,56832,83538,18343,03813,66116,31918,3210835483-346483000000
   Common Stock
0
0
0
0
0
0
1
1
0
1
1
1
1
1
3
2
2
2
3
3
3
4
4
4
4
5
5
7
8
10
1087554444333222311111011000000
   Retained Earnings Total Equity00000000-76,452-68,73700000-26,842-23,4510000000000000
   Accumulated Other Comprehensive Income 000000000000000-47,1340-27900-213-9,242-1690000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,211
69,877
0
0
0
0
0
85,522
98,247
0
0
0
0
0
0
0
0
0000000098,24785,5220000069,8772,2110000000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
238
238
0
523
0
1,458
1,819
2,211
69,877
70,872
71,669
72,581
82,975
83,941
85,522
98,247
101,375
116,152
117,303
122,026
124,079
136,127
141,075
147,529
147,529141,075136,127124,079122,026117,303116,152101,37598,24785,52283,94182,97572,58171,66970,87269,8772,2111,8191,45805230238238000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-2,655
Gross Profit-2,655-2,655
 
Operating Income (+$)
Gross Profit-2,655
Operating Expense-26,944
Operating Income-29,599-29,599
 
Operating Expense (+$)
Research Development16,962
Selling General Administrative12,637
Selling And Marketing Expenses0
Operating Expense26,94429,599
 
Net Interest Income (+$)
Interest Income230
Interest Expense-0
Other Finance Cost-0
Net Interest Income230
 
Pretax Income (+$)
Operating Income-29,599
Net Interest Income230
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,437-28,761
EBIT - interestExpense = -30,437
-30,437
-30,437
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-30,437-30,437
Earnings Before Interest and Taxes (EBITDA)-27,782
 
After tax Income (+$)
Income Before Tax-30,437
Tax Provision-0
Net Income From Continuing Ops-30,437-30,437
Net Income-30,437
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses29,599
Total Other Income/Expenses Net-838-230
 

Technical Analysis of In8bio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of In8bio. The general trend of In8bio is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine In8bio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. In8bio Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of In8bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.1 < 2.46 < 2.534.

The bearish price targets are: 1.91.

Know someone who trades $INAB? Share this with them.👇

In8bio Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of In8bio Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

In8bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of In8bio Inc. The current macd is -0.07309617.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the In8bio price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for In8bio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the In8bio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
In8bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartIn8bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of In8bio Inc. The current adx is 12.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell In8bio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
In8bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of In8bio Inc. The current sar is 2.19466171.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
In8bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of In8bio Inc. The current rsi is 39.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
In8bio Inc Daily Relative Strength Index (RSI) ChartIn8bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of In8bio Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the In8bio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
In8bio Inc Daily Stochastic Oscillator ChartIn8bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of In8bio Inc. The current cci is -113.2199829.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
In8bio Inc Daily Commodity Channel Index (CCI) ChartIn8bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of In8bio Inc. The current cmo is -24.52916366.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
In8bio Inc Daily Chande Momentum Oscillator (CMO) ChartIn8bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of In8bio Inc. The current willr is -76.92307692.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that In8bio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
In8bio Inc Daily Williams %R ChartIn8bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of In8bio Inc.

In8bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of In8bio Inc. The current atr is 0.12534838.

In8bio Inc Daily Average True Range (ATR) ChartIn8bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of In8bio Inc. The current obv is 1,547,267.

In8bio Inc Daily On-Balance Volume (OBV) ChartIn8bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of In8bio Inc. The current mfi is 27.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
In8bio Inc Daily Money Flow Index (MFI) ChartIn8bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for In8bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

In8bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of In8bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.354
Ma 20Greater thanMa 502.148
Ma 50Greater thanMa 1002.219
Ma 100Greater thanMa 2002.911
OpenGreater thanClose2.040
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of In8bio with someone you think should read this too:
  • Are you bullish or bearish on In8bio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about In8bio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about In8bio Inc

I send you an email if I find something interesting about In8bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about In8bio Inc.

Receive notifications about In8bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.